Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Damond

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
AIDS (London, England)|October 26, 2012
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNABenoit Visseaux, Charlotte Charpentier, Audrey Taieb, et al.
Antiviral Therapy|October 1, 2004
Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimenFlorence Damond, Sophie Matheron, Gilles Peytavin, et al.
AIDS (London, England)|September 30, 2014
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patientsBenoit Visseaux, Charlotte Charpentier, Caroline Rouard, et al.
Journal of Virology|January 10, 2020
Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional ActivityQuentin Le Hingrat, Benoit Visseaux, Mélanie Bertine, et al.
Virus Evolution|August 23, 2021
HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolutionBenoit Visseaux, Mélanie Bertine, Quentin Le Hingrat, et al.
AIDS (London, England)|September 10, 2011
Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimenLucile Larrouy, Charlotte Charpentier, Roland Landman, et al.
AIDS (London, England)|September 29, 2012
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patientsLucile Larrouy, Alexandre Vivot, Charlotte Charpentier, et al.
AIDS (London, England)|February 28, 2008
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in FranceJulia Drylewicz, Sophie Matheron, Estibaliz Lazaro, et al.
AIDS (London, England)|March 5, 2008
Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patientsFlorence Damond, Sylvie Lariven, Benedicte Roquebert, et al.
Plos One|August 7, 2015
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical IsolatesBenoit Visseaux, Charlotte Charpentier, Gilles Collin, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
AIDS (London, England)|October 26, 2012
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNABenoit Visseaux, Charlotte Charpentier, Audrey Taieb, et al.
Antiviral Therapy|October 1, 2004
Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimenFlorence Damond, Sophie Matheron, Gilles Peytavin, et al.
AIDS (London, England)|September 30, 2014
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patientsBenoit Visseaux, Charlotte Charpentier, Caroline Rouard, et al.
Journal of Virology|January 10, 2020
Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional ActivityQuentin Le Hingrat, Benoit Visseaux, Mélanie Bertine, et al.
Virus Evolution|August 23, 2021
HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolutionBenoit Visseaux, Mélanie Bertine, Quentin Le Hingrat, et al.
AIDS (London, England)|September 10, 2011
Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimenLucile Larrouy, Charlotte Charpentier, Roland Landman, et al.
AIDS (London, England)|September 29, 2012
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patientsLucile Larrouy, Alexandre Vivot, Charlotte Charpentier, et al.
AIDS (London, England)|February 28, 2008
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in FranceJulia Drylewicz, Sophie Matheron, Estibaliz Lazaro, et al.
AIDS (London, England)|March 5, 2008
Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patientsFlorence Damond, Sylvie Lariven, Benedicte Roquebert, et al.
Plos One|August 7, 2015
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical IsolatesBenoit Visseaux, Charlotte Charpentier, Gilles Collin, et al.
Pageof 12